NanoString Technologies, a life sciences tool company that is commercializing a novel and uniquely user-friendly technology for characterizing and quantifying expression profiles in complex biological samples, announced today that it has closed a $30 million Series C equity financing.
This will lead, for example, to new ways of growing stem cells, or manipulating cells in the organism and in bioreactor systems. These key technologies will ultimately contribute to the development of new therapies for many degenerative diseases that affect muscle, the retina or the central nervous system.
MDRNA, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi), announced today in vivo data from a bladder cancer model demo...
Aposense Ltd., a molecular imaging and drug development company, leading the translation of the science of apoptosis (programmed cell death) into clinical practice, today announced a collaboration with GlaxoSmithKline (G...
Canadian Light Source (CLS) staff scientist Luca Quaroni and Dr. Alan Casson, Head of the Department of Surgery at the University of Saskatchewan (U of S) used the synchrotron's infrared microscope to identify tissue afflicted with a condition known as Barrett's Esophagus from chemical fingerprints associated with the disease.
International experts in cancer research and proteomics are gathering in Dublin this week to discuss how the convergence of these research areas can improve the process of identifying new cancer biomarkers.
This flagshi...
The genome of complex organisms is stashed away inside each cell's nucleus, a little like a sovereign shielded from the threatening world outside. The genome cannot govern from its protective chamber, however, withou...
The Fresnel Prize recognizes the highest level of excellence amongst emerging researchers, under the age of 35, in the field of photonics. Two awards are given every second year, to fundamental and applied aspects. This year the award for applied photonics has been presented to Prof. Romain Quidant from ICFO.
Scientists of the Electronic Technology group of the University of Seville (US), led by Professor José Manuel Quero, have completed the first phase of Mireia, a research project financed by the Plan Nacional del Ministerio de Ciencia e Innovación (National Plan of the Spanish Science and Innovation Ministry), whose aim is to develop an intelligent chip to regulate diabetes in any kind of patients suffering this disease.
Thermo Fisher Scientific Inc., is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer, today announced a collaboration between its Biomarker Research Initiatives in ...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.